A sex-specific evolutionary interaction between ADCY9 and CETP
- Université de Montréal, Canada
- Montreal Heart Institute, Canada
- Broad Institute, United States
- Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Canada
- Socios En Salud, Peru
Abstract
Pharmacogenomic studies have revealed associations between rs1967309 in the adenylyl cyclase type 9 (ADCY9) gene and clinical responses to the cholesteryl ester transfer protein (CETP) modulator dalcetrapib, however, the mechanism behind this interaction is still unknown. Here, we characterized selective signals at the locus associated with the pharmacogenomic response in human populations and we show that rs1967309 region exhibits signatures of positive selection in several human populations. Furthermore, we identified a variant in CETP, rs158477, which is in long-range linkage disequilibrium with rs1967309 in the Peruvian population. The signal is mainly seen in males, a sex-specific result that is replicated in the LIMAA cohort of over 3,400 Peruvians. Analyses of RNA-seq data further suggest an epistatic interaction on CETP expression levels between the two SNPs in multiple tissues, which also differs between males and females. We also detected interaction effects of the two SNPs with sex on cardiovascular phenotypes in the UK Biobank, in line with the sex-specific genotype associations found in Peruvians at these loci. We propose that ADCY9 and CETP coevolved during recent human evolution due to sex-specific selection, which points towards a biological link between dalcetrapib’s pharmacogene ADCY9 and its therapeutic target CETP.
Data availability
- 1000 Genomes Project, GEUVADIS is freely available.- The Native American genetic dataset was shared to us upon request to the authors of the initial paper and through a data access agreement with Universidad de Antioquia (Prof. Omar Triana Chavez). We contacted bedoya.g@gmail.com and a.ruizlin@ucl.ac.uk to get access to the dataset and we completed a data access application form and signed a data access approval once approved. Applications for access to these data can be submitted at any time. These are considered on a rolling basis and a decision was given within 1 month of receipt. PhD student applicants must include their supervisors as a co-applicant and provide their full contact details. A publication list must be provided for the applicant, co-applicants and PhD supervisors where PhD students have applied to provide proof of competence in handling datasets of this size and nature. - UK Biobank was accessed through data access approval under the project number #15357 and #20168. Information to apply for data access can be found here: https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access - CARTaGENE biobank was accessed through data access approval under the project number #406713. Information to apply for data access can be found here: https://www.cartagene.qc.ca/en/researchers/access-request - GTEx v8 dataset was accessed through dbGaP under project number #19088 LIMAA dataset was accessed through dbGaP under the project number #26882. Information to apply for data access through dbGAP can be found here: https://dbgap.ncbi.nlm.nih.gov- RNA-sequencing of ADCY9-knocked-down HepG2 cell line data has been deposited under GSE174640 (embargo): https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174640For reviewers/editors: Enter token ktaxgqkkrxupjkl into the box- Source data files and code for all main figures are available here: https://github.com/HussinLab/adcy9_cetp_Gamache_2021
-
RNA-sequencing of ADCY9-knocked-down HepG2 cell line (embargo)NCBI Gene Expression Omnibus, GSE174640.
-
LIMAAdbGaP project #26882.
-
Native American genetic dataset (NAGD)rom authors bedoya.g@gmail.com and a.ruizlin@ucl.ac.uk.
Article and author information
Author details
Funding
Institut de Cardiologie de Montréal
- Isabel Gamache
- Marc-André Legault
- Jean-Christophe Grenier
- Rocio Sanchez
- Eric Rhéaume
- Holly Trochet
- Jean-Claude Tardif
- Marie-Pierre Dubé
- Julie Hussin
Université de Montréal
- Isabel Gamache
Canadian Institutes of Health Research
- Marc-André Legault
Canada Research Chairs
- Jean-Claude Tardif
- Marie-Pierre Dubé
Fonds de Recherche du Québec - Santé
- Julie Hussin
Institut de Valorisation des Données
- Isabel Gamache
- Jean-Christophe Grenier
- Julie Hussin
Health collaboration acceleration fund from the Ministère de l'Économie et de l'Innovation of the Government of Quebec
- Jean-Claude Tardif
- Marie-Pierre Dubé
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: The analyses done in this study were approved by the different cohorts used. Participants in these cohorts gave their general consent for their data to be used for research purposes. All individual-level data was anonymized and no efforts were made by the authors to deanonymize or recontact any of the participants from the cohorts, in keeping with our agreements with the UK Biobank, CARTaGENE, dbGAP, 1000Genomes and the Native American Genetics dataset (Universidad de Antioquia).
Copyright
© 2021, Gamache et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,122
- views
-
- 104
- downloads
-
- 8
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
A sex-specific evolutionary interaction between ADCY9 and CETP
eLife 10:e69198.
https://doi.org/10.7554/eLife.69198
Further reading
-
- Computational and Systems Biology
- Medicine
Excessive consumption of sucrose, in the form of sugar-sweetened beverages, has been implicated in the pathogenesis of metabolic dysfunction‐associated fatty liver disease (MAFLD) and other related metabolic syndromes. The c-Jun N-terminal kinase (JNK) pathway plays a crucial role in response to dietary stressors, and it was demonstrated that the inhibition of the JNK pathway could potentially be used in the treatment of MAFLD. However, the intricate mechanisms underlying these interventions remain incompletely understood given their multifaceted effects across multiple tissues. In this study, we challenged rats with sucrose-sweetened water and investigated the potential effects of JNK inhibition by employing network analysis based on the transcriptome profiling obtained from hepatic and extrahepatic tissues, including visceral white adipose tissue, skeletal muscle, and brain. Our data demonstrate that JNK inhibition by JNK-IN-5A effectively reduces the circulating triglyceride accumulation and inflammation in rats subjected to sucrose consumption. Coexpression analysis and genome-scale metabolic modeling reveal that sucrose overconsumption primarily induces transcriptional dysfunction related to fatty acid and oxidative metabolism in the liver and adipose tissues, which are largely rectified after JNK inhibition at a clinically relevant dose. Skeletal muscle exhibited minimal transcriptional changes to sucrose overconsumption but underwent substantial metabolic adaptation following the JNK inhibition. Overall, our data provides novel insights into the molecular basis by which JNK inhibition exerts its metabolic effect in the metabolically active tissues. Furthermore, our findings underpin the critical role of extrahepatic metabolism in the development of diet-induced steatosis, offering valuable guidance for future studies focused on JNK-targeting for effective treatment of MAFLD.
-
- Computational and Systems Biology
Manifold-learning is particularly useful to resolve the complex cellular state space from single-cell RNA sequences. While current manifold-learning methods provide insights into cell fate by inferring graph-based trajectory at cell level, challenges remain to retrieve interpretable biology underlying the diverse cellular states. Here, we described MGPfactXMBD, a model-based manifold-learning framework and capable to factorize complex development trajectories into independent bifurcation processes of gene sets, and thus enables trajectory inference based on relevant features. MGPfactXMBD offers a more nuanced understanding of the biological processes underlying cellular trajectories with potential determinants. When bench-tested across 239 datasets, MGPfactXMBD showed advantages in major quantity-control metrics, such as branch division accuracy and trajectory topology, outperforming most established methods. In real datasets, MGPfactXMBD recovered the critical pathways and cell types in microglia development with experimentally valid regulons and markers. Furthermore, MGPfactXMBD discovered evolutionary trajectories of tumor-associated CD8+ T cells and yielded new subtypes of CD8+ T cells with gene expression signatures significantly predictive of the responses to immune checkpoint inhibitor in independent cohorts. In summary, MGPfactXMBD offers a manifold-learning framework in scRNA-seq data which enables feature selection for specific biological processes and contributing to advance our understanding of biological determination of cell fate.
